Dermatofibrosarcoma Protuberans (DFSP), from the CureRays guide library.

DFSP is a rare, slow-growing skin sarcoma that almost never spreads but can come back locally — usually cured by specialized surgery, with radiation and a targeted pill available for difficult cases.

What it is.

Dermatofibrosarcoma protuberans, or DFSP, is a rare cancer that begins in the deep layer of the skin (the dermis) and is classified as a soft-tissue sarcoma of the skin. It usually appears as a slow-growing, firm patch or lump — often on the trunk, shoulders, or limbs — that may start as a small, painless area resembling a scar or a bruise and gradually thickens and rises over months or years (the name 'protuberans' refers to the way it eventually bulges outward). Because it grows so slowly, it is often present for a long time before it is diagnosed. The defining behavior of DFSP is the key to understanding it: it is locally aggressive but almost never spreads to other parts of the body. The cancer sends out finger-like, root-like extensions that creep outward through the skin well beyond what can be seen or felt, which is why it has a strong tendency to come back after removal if those hidden extensions are not fully cleared. Distant spread to the lungs or other organs is very rare and happens mainly with an uncommon, more aggressive variant. DFSP is driven by a specific, characteristic genetic change in the tumor cells (a rearrangement involving the PDGFB gene), which is important because it both helps confirm the diagnosis under the microscope and provides a target for a medication used in difficult cases. The cornerstone of treatment is surgery that removes the tumor along with a wide margin or with careful microscopic checking of the edges to catch those hidden roots. Radiation and a targeted oral drug are valuable additions for tumors that are hard to remove completely, that come back, or that are too extensive for surgery alone.

How radiation treats it.

Radiation therapy treats DFSP by delivering focused beams of energy that damage the DNA inside the tumor cells, so they lose the ability to grow and divide. The role of radiation in this cancer follows directly from how DFSP behaves. Its defining trait is that it sends out hidden, root-like extensions far beyond the visible edge of the tumor, which is why it tends to recur locally if those extensions are not completely removed — and why radiation, which can treat a wide area including microscopic disease, is such a useful partner to surgery. The most common use is after an operation: when the surgeon removes the tumor but the edges come back close to or involved by cancer and further surgery isn't practical, radiation to the surgical area treats any microscopic tumor cells left behind and substantially lowers the chance the cancer comes back. Radiation can also be the primary treatment for a tumor that cannot be removed because of its size or location, and it can be given before surgery to shrink a large tumor so that a complete, less disfiguring removal becomes possible. Because DFSP almost never spreads to distant organs, the goal of radiation is local control — eradicating the disease in and around the original site — rather than treating the whole body. Modern techniques such as intensity-modulated radiation shape the dose tightly around the target, protecting the surrounding skin and nearby structures, which matters when the tumor sits in a cosmetically or functionally important area. Used thoughtfully alongside specialized surgery, radiation makes durable local control achievable even for difficult, recurrent, or hard-to-remove tumors. For the small number of tumors driven by DFSP's characteristic genetic change that cannot be controlled with surgery and radiation, a targeted oral drug provides an additional, biology-based option.

The ways we can treat it.

Postoperative (adjuvant) radiation. Radiation to the surgical area after removal, used when the margins are close or positive and further surgery isn't practical, treats any microscopic tumor left behind and sharply reduces the chance of recurrence.

Definitive radiation. For a tumor that cannot be removed — for example, because of its size or location — focused external-beam radiation can serve as the primary treatment to control the disease.

Preoperative radiation in selected cases. Radiation given before surgery can shrink a large tumor and make a complete, less disfiguring removal more achievable.

Intensity-modulated radiation (IMRT). Shaping the radiation beams tightly around the target protects surrounding skin and structures, useful when the tumor is near cosmetically or functionally important areas.

Questions we hear often.

Is DFSP a dangerous cancer? DFSP is a true cancer, but a relatively favorable one because it almost never spreads to other parts of the body. Its main challenge is local: it sends out hidden root-like extensions and can come back where it started if those aren't completely removed. With complete removal, the great majority of people are cured. An uncommon, more aggressive variant carries a small risk of spreading and is watched more closely.

Why does it tend to come back, and how is that prevented? DFSP grows outward in thin, root-like extensions that reach well beyond the visible tumor, so a recurrence happens when some of those hidden roots are left behind. Prevention comes from surgery that removes the tumor with a wide margin or with careful microscopic checking of the edges, and from adding radiation when the margins are close or involved and further surgery isn't feasible.

When is radiation or the targeted pill used instead of just surgery? Surgery is the main treatment and cures most DFSP. Radiation is added when the surgical edges are close or involved and re-excision isn't practical, or used as the primary treatment for tumors that can't be removed. The targeted oral drug (imatinib), which blocks DFSP's driver gene, is used to shrink large or recurrent tumors before surgery and to treat the rare cases that spread.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.